Dolutegravir for first-line antiretroviral therapy in low-income and middle-income countries: uncertainties and opportunities for implementation and research

A new first-line antiretroviral therapy (ART) regimen containing dolutegravir is being rolled-out in low-income and middle-income countries (LMICs). Studies from predominantly high-income settings have found that dolutegravir-based regimens have superior efficacy, tolerability and durability compare...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Lancet HIV
Asıl Yazarlar: Dorward, Jienchi, Lessells, Richard, Drain, Paul K, Naidoo, Kogieleum, de Oliveira, Tulio, Pillay, Yogan, Karim, Salim S Abdool, Garrett, Nigel
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2018
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6063784/
https://ncbi.nlm.nih.gov/pubmed/29884404
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S2352-3018(18)30093-6
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller